Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112174909B details a green method for aprepitant intermediates using biomimetic catalysts, offering high purity and scalability for pharma supply chains.
Patent CN1115343C details a novel enzymatic route for chiral cyclopentene amines, offering cost-effective API intermediate manufacturing with high enantiomeric purity.
Novel acid-catalyzed isomerization route ensures high purity pharmaceutical intermediate supply chain stability and cost efficiency for global partners seeking reliable manufacturing.
Patent CN115286559B reveals a three-step route for Paxlovid key intermediate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel asymmetric acetal method for (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one synthesis. High ee%, low cost, scalable process for API manufacturing.
Patent CN110627673B details a high-purity route for Formoterol intermediates using borane reduction, offering significant cost and supply chain advantages for API manufacturers.
Patent CN114507177B reveals a base-promoted synthesis route for isoindolinone intermediates using carbon dioxide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN121318680A enables high-yield Bexagliflozin intermediate production with reduced costs and supply chain reliability for global buyers.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Patent CN113195454A reveals a novel synthesis route for Formula VI intermediates, offering superior purity over 99% and safer Lewis acid demethylation for scalable API manufacturing.
Discover the advanced synthesis of (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride. A cost-effective, scalable route for pharmaceutical supply chains.
Novel telescoping route for DPP1 inhibitor intermediate ensures high purity and scalable production for global pharmaceutical supply chains seeking cost reduction.
Patent CN109574797B reveals a green aqueous route for S-Int A. Achieve 99.9% ee and simplified purification for antifungal API manufacturing.
Novel NHPI catalyzed process for Entecavir intermediates offers high yield and scalability for reliable pharmaceutical intermediates supplier partnerships.
Novel 4-step synthesis from L-Leucine avoids expensive reagents. Offers cost reduction and scalable supply for pharmaceutical manufacturing partners.
Patent CN106749255B offers improved Mitsunobu reaction for entecavir. Enhances yield and supply chain reliability for pharmaceutical intermediates.
Patent CN105820113A details a robust chiral resolution method for Crizotinib intermediates. This process ensures high purity, operational simplicity, and substantial cost reduction in pharmaceutical manufacturing.
Patent CN109956886A reveals high-purity Eliquis intermediate synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN111825614B reveals a safer, high-yield route for gliquidone intermediates, offering significant cost and safety advantages for API manufacturers.
Patent CN103951549B offers high-yield celecoxib intermediate synthesis. Reduces waste and cost for pharmaceutical intermediates manufacturing supply chains.